<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T07:28:58+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>天境生物CD47抗体lemzoparlimab I期数据公布：在实体瘤患者中观察到初步疗效信号 | 第一现场</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Th4Lb6qK7TNva3PZM6GbjA</id>
    <link href="https://mp.weixin.qq.com/s/Th4Lb6qK7TNva3PZM6GbjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月21日客论直播 ∣ 临床运营负责人分享MRCT策略及实践</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/YdXtDuo1qZJ38hRzFofz6A</id>
    <link href="https://mp.weixin.qq.com/s/YdXtDuo1qZJ38hRzFofz6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1类创新化药贺普拉肽治疗慢性乙肝Ⅱ期临床试验启动 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/EXCWO4XGRJ1H_G5uGlQk2w</id>
    <link href="https://mp.weixin.qq.com/s/EXCWO4XGRJ1H_G5uGlQk2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020中国肿瘤学大会：聚焦新疗法与新理念 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Dk-n2lKwoLGl_fg6No-kSQ</id>
    <link href="https://mp.weixin.qq.com/s/Dk-n2lKwoLGl_fg6No-kSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>探索中国创新药企的专科之路｜遇见潘柯</title>
    <updated>2020-11-15T22:39:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ezEFfVgKl4XrQc9O3L8R7g</id>
    <link href="https://mp.weixin.qq.com/s/ezEFfVgKl4XrQc9O3L8R7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈思渊：希望尽快将我们的创新产品引入中国 | 进博会专题</title>
    <updated>2020-11-13T21:44:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/RKEfMxO4bF281hu93rY0cw</id>
    <link href="https://mp.weixin.qq.com/s/RKEfMxO4bF281hu93rY0cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Tavotek：创新有序, 用技术之手突破成药障碍 | 江湖</title>
    <updated>2020-11-13T21:44:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/BfHrU0rxZVB9MTtZQzBnUQ</id>
    <link href="https://mp.weixin.qq.com/s/BfHrU0rxZVB9MTtZQzBnUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺和诺德黑科技——胰岛素发现100年再畅想 | 光影 · 世界糖尿病日专题</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Qtq9Q4SJTpiq96r3lg3HSA</id>
    <link href="https://mp.weixin.qq.com/s/Qtq9Q4SJTpiq96r3lg3HSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺和诺德在进博会宣布“中国同创”2.0计划    助力中国跻身全球医药创新第一梯队 | 新闻稿</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/KupBfPKLhWAMemeexEvIDw</id>
    <link href="https://mp.weixin.qq.com/s/KupBfPKLhWAMemeexEvIDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BiG巨献：三大院士、四门论坛、六十大咖、五百盛会！| 会议</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/nREo13mscGGDKCJRlv1VJw</id>
    <link href="https://mp.weixin.qq.com/s/nREo13mscGGDKCJRlv1VJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>与华西、湘雅达成战略合作  礼来全力参与中国临床研究生态建设 | 进博会专题</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/c6BhbJbzvkdz1Eye97cJ1g</id>
    <link href="https://mp.weixin.qq.com/s/c6BhbJbzvkdz1Eye97cJ1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晶泰科技与华东医药签署合作协议，AI将参与又一款抗肿瘤新药研发 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/gL3Aa9Ic07O0EHitM5aJtA</id>
    <link href="https://mp.weixin.qq.com/s/gL3Aa9Ic07O0EHitM5aJtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境生物在2020年SITC年会上公布肿瘤免疫新靶点抗体TJ210/MOR210临床前数据 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/2lMGEn0JVU7XJ4XHTXz3Iw</id>
    <link href="https://mp.weixin.qq.com/s/2lMGEn0JVU7XJ4XHTXz3Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚虹医药宣布完成D轮融资 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/NR7PzFNf2v2cPz-zp7vdCA</id>
    <link href="https://mp.weixin.qq.com/s/NR7PzFNf2v2cPz-zp7vdCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新为医药与海和药物宣布达成新型抗生素战略合作 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/W4DCWuBxRjNQ3J7ZP_ppxw</id>
    <link href="https://mp.weixin.qq.com/s/W4DCWuBxRjNQ3J7ZP_ppxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索元生物首个国际多中心Ⅲ期临床试验顺利完成受试者入组 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/mtKL3cKTr8DjPSEgO1ZQgw</id>
    <link href="https://mp.weixin.qq.com/s/mtKL3cKTr8DjPSEgO1ZQgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东的百年抗疫之路带给我们什么启示？| 进博会专题</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/JakJ4Jcd5bxMykzQJnZkTw</id>
    <link href="https://mp.weixin.qq.com/s/JakJ4Jcd5bxMykzQJnZkTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康宁杰瑞KN026联合KN046临床Ⅰb期研究数据亮相癌症免疫治疗学会年会（SITC 2020）| 新闻稿</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2TNhozwdJ0tAYBkpuj0N5g</id>
    <link href="https://mp.weixin.qq.com/s/2TNhozwdJ0tAYBkpuj0N5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒及受试者权益保护国际研讨会暨CIOMS《药物性肝损伤（DILI）国际共识》发布会下周召开！｜新闻稿</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/_msxQrPJlxk0knNAdHf9Wg</id>
    <link href="https://mp.weixin.qq.com/s/_msxQrPJlxk0knNAdHf9Wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201111 本周职位精选：临床、PV、R&amp;D、CMC、市场 | 招聘</title>
    <updated>2020-11-10T21:52:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/XyS7a4QhiNQyjZ194TDF7w</id>
    <link href="https://mp.weixin.qq.com/s/XyS7a4QhiNQyjZ194TDF7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>